- Home
- CNF vs MIST Comparison
CNF vs MIST Comparison
Compare CNF & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNF
- MIST
- Stock Information
- Founded
- CNF 1999
- MIST 2003
- Country
- CNF China
- MIST Canada
- Employees
- CNF N/A
- MIST N/A
- Industry
- CNF Finance: Consumer Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- CNF Finance
- MIST Health Care
- Exchange
- CNF Nasdaq
- MIST Nasdaq
- Market Cap
- CNF N/A
- MIST 53.9M
- IPO Year
- CNF 2018
- MIST N/A
- Fundamental
- Price
- CNF $0.72
- MIST $1.20
- Analyst Decision
- CNF
- MIST Strong Buy
- Analyst Count
- CNF 0
- MIST 2
- Target Price
- CNF N/A
- MIST $9.50
- AVG Volume (30 Days)
- CNF 127.5K
- MIST 1.6M
- Earning Date
- CNF 05-20-2025
- MIST 05-20-2025
- Dividend Yield
- CNF N/A
- MIST N/A
- EPS Growth
- CNF N/A
- MIST N/A
- EPS
- CNF 0.08
- MIST N/A
- Revenue
- CNF $82,730,950.00
- MIST N/A
- Revenue This Year
- CNF $264.82
- MIST N/A
- Revenue Next Year
- CNF N/A
- MIST N/A
- P/E Ratio
- CNF $8.82
- MIST N/A
- Revenue Growth
- CNF N/A
- MIST N/A
- 52 Week Low
- CNF $0.60
- MIST $0.63
- 52 Week High
- CNF $2.84
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- CNF 45.73
- MIST 48.24
- Support Level
- CNF $0.63
- MIST $1.28
- Resistance Level
- CNF $0.96
- MIST $1.46
- Average True Range (ATR)
- CNF 0.09
- MIST 0.12
- MACD
- CNF 0.01
- MIST 0.04
- Stochastic Oscillator
- CNF 27.27
- MIST 55.17
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).